Open Letter Calls for Control Over Synthetic DNA

Leading AI companies, scientists, and biosecurity experts have called for new legal regulations to strengthen control over synthetic DNA and RNA in an open letter. The letter was published to highlight growing concerns that powerful AI systems could facilitate the development of biological weapons. This concern has increased in recent years as the technology for manipulating genetic materials becomes more accessible. The signatories of the letter argue that current legal frameworks are insufficient to mitigate the risks associated with the use of AI in synthetic biology. They demand a comprehensive review of existing laws and the introduction of new guidelines specifically addressing the challenges of modern biotechnology.

The open letter has been signed by more than 100 leading figures from the technology and science sectors. A central concern of the signatories is the possibility that AI-driven systems could design genetic sequences that could potentially be used as biological weapons. This technology could enable individuals or groups to create dangerous pathogens that are difficult to detect and control. The signatories emphasize that regulating these technologies is crucial to ensuring public safety. The discussion about regulating synthetic biology is not new, but it has gained urgency due to advancements in AI and genome editing.

Experts warn that without appropriate controls, the risk of misuse could significantly increase. Therefore, the open letter calls not only for legislative measures but also for enhanced collaboration between governments, scientists, and industry. Another point raised in the letter is the need to establish ethical standards for research and development in the field of synthetic biology. The signatories urge that ethical considerations be integrated into all phases of research to ensure that the technology is used responsibly. This could also include the establishment of ethics committees to oversee and evaluate research.

Reactions to the open letter are mixed. While some experts welcome the initiative and emphasize the need for regulation, there are also voices warning against excessive restrictions. Critics argue that overly stringent regulations could hinder innovation in biotechnology. They advocate for a balanced approach that considers both safety and progress. The discussion about the regulation of AI and synthetic biology is expected to intensify in the coming months.

Governments worldwide are under pressure to take appropriate measures to minimize the risks associated with these technologies. In the United States, the National Institutes of Health (NIH) has already announced that it will review existing guidelines on synthetic biology. The signatories of the open letter emphasize that the time to act is now. They urge governments to take proactive steps to ensure that advancements in AI and synthetic biology do not pose a threat to public health and safety. The open letter was published on June 1, 2026, and has already sparked a broad discussion about the future regulation of these technologies. The debate over the control of synthetic DNA and RNA is also being conducted at the international level. The World Health Organization (WHO) has announced that it will address the challenges of synthetic biology. This could lead to a global framework governing safety and ethical standards in the research and development of biotechnologies. The signatories of the letter call for a clear definition of responsibilities for companies and researchers working in the field of synthetic biology.

They emphasize that transparency and accountability are crucial to ensuring public trust in these technologies. Such a framework could also help promote collaboration among various stakeholders in the biotechnology sector. The discussion about the regulation of AI and synthetic biology will continue to be pursued by experts and policymakers. The need to minimize risks while fostering innovation remains a central challenge. The signatories of the open letter hope that their initiative will lead to concrete actions to ensure safety in the field of synthetic biology. The WHO plans to hold an international conference in July 2026 to discuss the challenges and opportunities of synthetic biology.